Bio-identical testosterone reverses bone loss in older women

This study is based upon an 18 year study of a Caucasian woman beginning at the age of 60. She suspected that something was wrong with her body but was unaware of what that was. Her chiropractor took x-rays of her neck since she was complaining of pain in that area. Low bone density of her neck appeared on that scan. She was referred to her primary care doctor and he referred her for a dexa-scan of her lumbar spine and leg. The results indicated that she had osteoporosis of her lumbar spine and femoral neck, and osteopenia of the total hip. The standard treatment for osteoporosis at that time was administration of Fosamax, which she did start using upon the advice of her doctor. After about a year of use, she began having symptoms of jaw bone necrosis. The subject was a very well educated women, with some experience in research. It was at this point that she began to question the use of Fosamax and began her investigation into other methods of increasing bone density. Her curiosity led her to research bio-identical hormone therapy and eventually found a doctor who was willing to prescribe this therapy for her. Her research background and curiosity about an alternative treatment for osteoporosis led her to begin documentation and study over the course of 18 years on the role of a small amount of bio-identical testosterone for women and a possible alternative for improving bone density in women. Dexa-Scans were done every two years and she kept every record of these scans over the 18 year study. She charted the Bone Mineral Density and T-score of the lumbar spine, total hip and femoral neck. She observed that the bone density increased and the T-score decreased over the 18 year period. Her hypothesis was that bio-identical testosterone was a contributing factor in these results and was hopeful that further studies by others would validate her results.